Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

Producción del medicamento Benlysta y de la sede de la farmacéutica GlaxoSmithKline

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
787 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Apr 12, 2011

Por primera vez en más de 50 años, la FDA aprueba un medicamento para tratar los síntomas del lupus eritematoso sistémico. Este medicamento, Benlysta, es mercadeado en Estados Unidos y Puerto Rico por la farmacéutica GlaxoSmithKline.

*Imágenes de la producción del medicamento Benlysta y de la sede de la farmacéutica GlaxoSmithKline, cortesía de las farmacéuticas Human Genome Sciences, Inc., y GlaxoSmithKline.

Category:

Science & Technology

Tags:

License:

Standard YouTube License

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more